Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer

Author

Duda, Dan G.

Source

ISRN Cell Biology

Issue

Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-11, 11 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2012-12-17

Country of Publication

Egypt

No. of Pages

11

Main Subjects

Biology

Abstract EN

Antiangiogenic therapy for cancer has gone from an intriguing hypothesis in the 1970s to an accepted treatment approach for many cancer types.

It has also become a standard of care for certain eye diseases.

Yet, despite the use of molecularly targeted drugs with well defined targets, to date there are no biomarkers to guide the use of antiangiogenic therapy in patients.

The mechanisms of action of these drugs are also being debated.

This paper discusses some of the emerging biomarker candidates for this type of cancer therapy, which have provided mechanistic insight and might be useful in the future for optimizing cancer treatment.

American Psychological Association (APA)

Duda, Dan G.. 2012. Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer. ISRN Cell Biology،Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-483016

Modern Language Association (MLA)

Duda, Dan G.. Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer. ISRN Cell Biology No. 2012 (2012), pp.1-11.
https://search.emarefa.net/detail/BIM-483016

American Medical Association (AMA)

Duda, Dan G.. Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer. ISRN Cell Biology. 2012. Vol. 2012, no. 2012, pp.1-11.
https://search.emarefa.net/detail/BIM-483016

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-483016